(Q48085548)

8 February 2018

title

Health-related quality-of-life and treatment targets in myasthenia gravis. (English)

1 reference

8 February 2018

0 references

1 reference

3

Yuriko Nagane

1 reference

8 February 2018

1

Kimiaki Utsugisawa

1 reference

8 February 2018

5

Hiroyuki Murai

1 reference

8 February 2018

Shigeaki Suzuki

2

Shigeaki Suzuki

1 reference

8 February 2018

Norihiro Suzuki

12

Norihiro Suzuki

1 reference

8 February 2018

Yasushi Suzuki

10

Yasushi Suzuki

1 reference

8 February 2018

Tomihiro Imai

6

Tomihiro Imai

1 reference

8 February 2018

Emiko Tsuda

7

Emiko Tsuda

1 reference

8 February 2018

Shingo Konno

8

Shingo Konno

1 reference

8 February 2018

Shunya Nakane

9

Shunya Nakane

1 reference

8 February 2018

Kazuo Fujihara

11

Kazuo Fujihara

1 reference

8 February 2018

author name string

Masayuki Masuda

4

1 reference

8 February 2018

publication date

30 August 2014

1 reference

8 February 2018

published in

Muscle and Nerve

1 reference

8 February 2018

volume

50

1 reference

8 February 2018

issue

4

1 reference

8 February 2018

page(s)

493-500

1 reference

8 February 2018

Autoimmune myasthenia gravis

cites work

1 reference

Immunosuppressive therapies in myasthenia gravis

21 January 2018

1 reference

The MG-QOL15 Japanese version: validation and associations with clinical factors.

21 January 2018

1 reference

Lifetime course of myasthenia gravis

21 January 2018

1 reference

21 January 2018

1 reference

Quality of life and well-being of patients with myasthenia gravis.

21 January 2018

1 reference

History of outcome measures for myasthenia gravis

21 January 2018

1 reference

Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America

21 January 2018

1 reference

Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis

21 January 2018

1 reference

The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis

21 January 2018

1 reference

Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite

21 January 2018

1 reference

The MG Composite: A valid and reliable outcome measure for myasthenia gravis

21 January 2018

1 reference

Overlooked non-motor symptoms in myasthenia gravis

21 January 2018

1 reference

Factors associated with depressive state in patients with myasthenia gravis: a multicentre cross-sectional study

21 January 2018

1 reference

Two-year treatment with cyclosporine microemulsion for responder myasthenia gravis patients

21 January 2018

1 reference

Early aggressive treatment strategy against myasthenia gravis

21 January 2018

1 reference

Myasthenia gravis in the elderly: Is it different?

21 January 2018

1 reference

Evidence of underdiagnosis of myasthenia gravis in older people

21 January 2018

1 reference

Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis

21 January 2018

1 reference

Psychometric evaluation of the myasthenia gravis composite using Rasch analysis

21 January 2018

1 reference

Changes in quality of life scores with intravenous immunoglobulin or plasmapheresis in patients with myasthenia gravis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.24213

1 reference

8 February 2018

PubMed ID

24536040

1 reference

8 February 2018